Qeadan, Fares

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: a real-world data analysis

Qeadan, F., McCunn, A., & Tingey, B. (2025) · Addiction

Opioid Use Disorder TreatmentDiabetes Treatment and Management

Cited by 90

Outpatient visits versus telephone interviews for postoperative care: a randomized controlled trial

Thompson, J. C., Cichowski, S. B., Rogers, R. G., Qeadan, F., Zambrano, J., Wenzl, C., Jeppson, P. C., Dunivan, G. C., & Komesu, Y. M. (2019) · International Urogynecology Journal

Patient Satisfaction in HealthcareTelemedicine and Telehealth Implementation

Cited by 82

Association Between Hypertensive Disorders of Pregnancy and Dementia: a Systematic Review and Meta-Analysis

Schliep, K. C., Mclean, H., Yan, B., Qeadan, F., Theilen, L. H., de Havenon, A., Majersik, J. J., Østbye, T., Sharma, S., & Varner, M. W. (2023) · Hypertension

Pregnancy and preeclampsia studiesDementia and Cognitive Impairment Research

Cited by 69

Unemployment rate, opioids misuse and other substance abuse: quasi-experimental evidence from treatment admissions data

Azagba, S., Shan, L., Qeadan, F., & Wolfson, M. (2021) · BMC Psychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 47

Explaining Variability in Electronic Health Record Effort in Primary Care Ambulatory Encounters

Overhage, J. M., Qeadan, F., Choi, E. H. E., Vos, D., & Kroth, P. J. (2024) · Applied Clinical Informatics

Electronic Health Records SystemsMedical Coding and Health Information

Cited by 13